Wire Stories
BeiGene and NewBridge Pharmaceuticals Announce Approval in Saudi Arabia of BRUKINSA� (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
BRUKINSA is now approved for the treatment of MCL in 11 countries and regions, including the United States, China, Canada, Australia, Brazil,...